Multicenter Study
doi: 10.1097/QAD.0000000000002403.
Polypharmacy and evaluation of anticholinergic risk in a cohort of elderly people living with HIV
Affiliations
- PMID: 31764110
- DOI: 10.1097/QAD.0000000000002403
Item in Clipboard
Multicenter Study
Polypharmacy and evaluation of anticholinergic risk in a cohort of elderly people living with HIV
AIDS.
.
Abstract
: As a consequence of ageing, the number of prescribed medications for people living with HIV is increasing. Concomitant use of different drugs and their potential interactions may increase anticholinergic exposure and escalate the risk for side effects. We conducted an analysis in our cohort of people living with HIV over 50 years of age to evaluate the overall anticholinergic risk, as it is useful to identify, prevent, and manage increased side effect risks.
Similar articles
-
Features of anticholinergic prescriptions and predictors of high use in the elderly: Population-based study.Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1591-1600. doi: 10.1002/pds.4902. Epub 2019 Nov 6. Pharmacoepidemiol Drug Saf. 2019. PMID: 31692168
-
Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort study.J Antimicrob Chemother. 2022 Feb 2;77(2):492-499. doi: 10.1093/jac/dkab386. J Antimicrob Chemother. 2022. PMID: 34734255 Review.
-
Disentangling the Effects of Comorbidity and Polypharmacy on Cognitive Function and Physical Frailty in Individuals With HIV.J Acquir Immune Defic Syndr. 2024 Dec 15;97(5):497-505. doi: 10.1097/QAI.0000000000003523. J Acquir Immune Defic Syndr. 2024. PMID: 39250337
-
Anticholinergic and sedative medications exposure in older patients: a cross-sectional study.Int J Clin Pharm. 2019 Oct;41(5):1152-1158. doi: 10.1007/s11096-019-00885-5. Epub 2019 Aug 7. Int J Clin Pharm. 2019. PMID: 31392583
-
Anticholinergic side-effects of drugs in elderly people.J R Soc Med. 2000 Sep;93(9):457-62. doi: 10.1177/014107680009300903. J R Soc Med. 2000. PMID: 11089480 Free PMC article. Review. No abstract available.
Cited by
-
Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis.Ther Adv Drug Saf. 2022 Aug 23;13:20420986221080795. doi: 10.1177/20420986221080795. eCollection 2022. Ther Adv Drug Saf. 2022. PMID: 36052397 Free PMC article.
-
Anticholinergic burden measures, symptoms, and fall-associated risk in older adults with polypharmacy: Development and validation of a prognostic model.PLoS One. 2023 Jan 23;18(1):e0280907. doi: 10.1371/journal.pone.0280907. eCollection 2023. PLoS One. 2023. PMID: 36689445 Free PMC article.
-
Current Considerations for Clinical Management and Care of People with HIV: Findings from the 11th Annual International HIV and Aging Workshop.AIDS Res Hum Retroviruses. 2021 Nov;37(11):807-820. doi: 10.1089/AID.2021.0059. Epub 2021 Sep 20. AIDS Res Hum Retroviruses. 2021. PMID: 34405689 Free PMC article.
-
Treatment and comorbidity burden among people living with HIV: a review of systematic literature reviews.J Drug Assess. 2022 Dec 23;12(1):1-11. doi: 10.1080/21556660.2022.2149963. eCollection 2023. J Drug Assess. 2022. PMID: 36582675 Free PMC article.
-
Real-Life Experience on Dolutegravir and Lamivudine as Initial or Switch Therapy in a Silver Population Living with HIV.Viruses. 2023 Aug 15;15(8):1740. doi: 10.3390/v15081740. Viruses. 2023. PMID: 37632082 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
